IL33 and melanoma: This assumption is supported not only by up-regulation of IL-33 expression in mouse and human melanoma cells following exposure to DAC but also by the organ-on-chip experiments, which underscored a crosstalk between DAC exposed tumor cells and ST2-expressing immune cells, likely via tumor released IL-33.